News Archive

MHRA - Medicines: licensing time-based performance measures

11th November 2021

Medicines: licensing time-based performance measures

Read More+

PIC/S Concept Papers on the revision of EU-PIC/S GMP Annexes 4 & 5

11th November 2021

The PIC/S Working Group on Veterinary Medicinal Products (VMP), led by Grégory Verdier (France / ANSES), and the EMA GMP/GDP Inspectors Working Group have jointly developed two concept papers on the revision of Annex 4 (manufacture of veterinary medicinal products other than immunologicals) and Annex 5 (manufacture of immunological veterinary medicinal products) of the EU-PIC/S GMP Guide.

Read More+

WHO - International organisations, vaccine manufacturers take stock of COVID-19 vaccine roll out, share views for 2022

11th November 2021

International organisations, vaccine manufacturers take stock of COVID-19 vaccine roll out, share views for 2022

Read More+

EMA - Invitation to the 4th public stakeholder meeting on COVID-19 therapeutics and vaccines in the EU

4th November 2021

Invitation to the 4th public stakeholder meeting on COVID-19 therapeutics and vaccines in the EU

Read More+

MHRA - First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA

4th November 2021

The antiviral was found to be safe and effective following a stringent review of the available evidence.

Read More+

EMA - Generating high-quality evidence from registry-based studies

27th October 2021

EMA has published guidance to provide key methods and good regulatory practices to pharmaceutical organisations on the planning and conduct of registry-based studies.

Read More+

MHRA - launches public consultation on future of medical device regulation

27th October 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting members of the public to provide their views on possible changes to the regulatory framework for medical devices in the United Kingdom (UK).

Read More+

MHRA - Upcoming Board Meeting

27th October 2021

The next MHRA Board meeting will take place on the 16th November. The general public can attend this virtual meeting.

Read More+

ICH - The ICH E8(R1) Guideline reaches Step 4 of the ICH Process

12th October 2021

The ICH E8(R1) Guideline on General considerations for Clinical Studies reached Step 4 of the ICH Process on 6 October 2021.

Read More+

EC - Good Lay Summary Practice Guidance

7th October 2021

This “Good Lay Summary Practice” (“GLSP”) provides recommendations on how to prepare, write, translate, and disseminate summaries of clinical trial results in lay language. This is a mandatory requirement laid out in Regulation (EU) No. 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use (“EU CTR”) and a transparency obligation to all trial participants and the interested public.

Read More+